Brian Callaghan
University of Michigan
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Brian Callaghan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:10 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07795593 · Modality Choice Before and After Failure for the Treatment of Painful Diabetic NeuropathyUniversity of Michigan · not yet recruiting · Painful Diabetic Neuropathy (PDN), Diabetic Nephropathies · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Effectiveness and Cost-effectiveness in Alzheimer’s TreatmentR33AG088891 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2025 to 2026 · $622,361 awarded in 2026Same name and institution; not confirmed by an ID
- Health Equity in Alzheimer’s Treatment (HEAT)R61AG088891 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2024 · $331,439 awarded in 2024Same name and institution; not confirmed by an ID
- The Effect of High Intensity Interval Training and Surgical Weight Loss On Distal Symmetric Polyneuropathy OutcomesR01DK115687 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2018 to 2022 · $611,500 awarded in 2022Same name and institution; not confirmed by an ID
- The Impact of the Metabolic Syndrome on NeuropathyK23NS079417 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · fiscal years 2013 to 2017 · $187,380 awarded in 2017Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:10 UTC. The ranking covers the 200 most relevant of 8 PubMed records, and a shared surname and initials can bring in a namesake. All 8 on PubMed
- Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study.J Diabetes Complications · 201581 citationsRCR 3.1
- Identification of factors associated with sural nerve regeneration and degeneration in diabetic neuropathy.Diabetes Care · 201334 citationsRCR 1.1
- Sudomotor dysfunction as a measure of small fiber neuropathy in type 1 diabetes.Auton Neurosci · 201723 citationsRCR 1.2
- 22 citationsRCR 1.2
- Randomized controlled trial of a clinical decision support system for painful polyneuropathy.Muscle Nerve · 20208 citationsRCR 0.7
- Comparison of intraepidermal nerve fiber density and confocal corneal microscopy for neuropathy.Ann Clin Transl Neurol · 20248 citationsRCR 1.6
- 5 citationsRCR 0.3
- 3 citationsRCR 1.1